pharmaco

17 July 2018
Pharmablue
Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...
Rare diseases: At the core of our mission At PharmaBlue, we’ve spent the past decade...
About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...